A roundup of some of the more unusual items that crossed our desk recently.
FDA approval would expand that practice and could make the highly expensive medicine more affordable and may lead many more insurance companies to pay for the drug.. ...
Insiders know more, are better prepared and generally more successful. Today's top advisors subscribe to our premium newsletter to ensure that they don't miss out the most important industry changes that are happening in real time. Starting at $8.95/Mo.